• NRC posted Q1 net income of $3.22 million, down 44%.
• Revenue rose 4% to $34.8 million, while operating income fell 35% to $5.57 million as selling, general and administrative expense jumped 30% to $13.42 million.
• Adjusted EBITDA slipped 8.9% to $9.41 million, trimming adjusted EBITDA margin by 3.8 percentage points to 27%.
• Total Recurring Contract Value climbed 13% to $152.07 million, while cash provided by operating activities increased 8% to $7.18 million.
• In April, board committee amended certain 2025 executive equity awards, driving an expected $9.4 million second-quarter expense including $6.5 million of accelerated non-cash equity compensation and $2.9 million of cash bonus expense tied mainly to tax payments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRC - National Research Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-015083), on May 06, 2026, and is solely responsible for the information contained therein.